Novo Nordisk A (NVO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NVO Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Novo Nordisk A finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash, Cash Equivalents Other0.00
Current Tax Assets Current761.79
Cash & Short-term Investments761.00
Accounts receivable11,133.88
Inventories7,797.45
Other Current Assets47,126.00
Total Current Assets27,098.21
Goodwill net3,118.32
Intangible Assets0.00
Deferred Tax Assets3,715.74
Other Assets, Noncurrent11,655.11
Total Assets85,308.30
Liabilities
Short-term Debt0.00
Other Liabilities, Current0.00
Current Provisions58.77
Total Current Liabilities33,887.65
Long-term debt0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI1,038.81
Noncurrent Provisions53,719.36
Total Liabilities54,816.94
Stockholders' Equity
Other Equity194,047.00
Common Stockholder's Equity30,491.36
Total Stockholder's Equity30,491.36
Liabilities & Stockholder's Equity85,308.30
4 historic quarters locked

Sign in to unlock the full Novo Nordisk A balance sheet history.

About Novo Nordisk A S Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 4, 2026
  • Source: nvo-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000353278-26-000012

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.